Overview

Lipitor as a Treatment for Alzheimer's Disease

Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the clinical benefit of Lipitor, a cholesterol-lowering drug, in the treatment of Alzheimer's disease.
Phase:
Phase 2
Details
Lead Sponsor:
Institute for the Study of Aging (ISOA)
Collaborator:
Pfizer
Treatments:
Atorvastatin
Atorvastatin Calcium
Calcium
Calcium, Dietary